Import input compliance: Lavofloxacin Hemihydrate inputs must match declared manufacturing proportions and actual use in exported products. Suspension of import-authorisation for Lavofloxacin Hemihydrate is recorded under Public Notice No. 03/2024-25; applicants remain subject to verification of permissible input proportions and must ensure imported goods correspond to inputs used or required in the declared export product.